B. Metzler seel. Sohn & Co. AG Sells 6,554 Shares of The Cigna Group (NYSE:CI)

B. Metzler seel. Sohn & Co. AG cut its stake in shares of The Cigna Group (NYSE:CI - Free Report) by 27.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 17,120 shares of the health services provider's stock after selling 6,554 shares during the period. B. Metzler seel. Sohn & Co. AG's holdings in The Cigna Group were worth $4,728,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. TCTC Holdings LLC acquired a new position in The Cigna Group in the 4th quarter worth approximately $25,000. Collier Financial purchased a new stake in shares of The Cigna Group in the fourth quarter valued at $32,000. ORG Wealth Partners LLC acquired a new stake in shares of The Cigna Group in the fourth quarter worth $34,000. Compagnie Lombard Odier SCmA purchased a new position in shares of The Cigna Group during the fourth quarter valued at $37,000. Finally, Heck Capital Advisors LLC acquired a new position in The Cigna Group during the fourth quarter valued at $53,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at The Cigna Group

In related news, CEO David Cordani sold 26,527 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $308.12, for a total value of $8,173,499.24. Following the completion of the sale, the chief executive officer now owns 127,767 shares in the company, valued at approximately $39,367,568.04. This trade represents a 17.19 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Elder Granger sold 2,376 shares of the business's stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $310.35, for a total value of $737,391.60. Following the transaction, the director now owns 5,471 shares in the company, valued at $1,697,924.85. This represents a 30.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 43,751 shares of company stock worth $13,603,991. Insiders own 0.70% of the company's stock.

Remove Ads

Analysts Set New Price Targets

CI has been the topic of several research analyst reports. Barclays lowered their target price on The Cigna Group from $420.00 to $339.00 and set an "overweight" rating on the stock in a research note on Friday, January 31st. Royal Bank of Canada set a $355.00 target price on shares of The Cigna Group in a research report on Friday, January 31st. Sanford C. Bernstein cut shares of The Cigna Group from an "outperform" rating to a "market perform" rating and set a $323.00 price target on the stock. in a report on Thursday, February 6th. Oppenheimer cut their price objective on The Cigna Group from $400.00 to $375.00 and set an "outperform" rating for the company in a report on Friday, January 31st. Finally, Wells Fargo & Company lowered their target price on The Cigna Group from $370.00 to $341.00 and set an "equal weight" rating on the stock in a research note on Tuesday, February 4th. Two analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and three have given a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Buy" and a consensus target price of $373.25.

The Cigna Group Stock Performance

Shares of NYSE:CI traded up $6.84 during trading on Thursday, reaching $338.76. The stock had a trading volume of 2,403,842 shares, compared to its average volume of 1,655,879. The stock has a fifty day simple moving average of $307.29 and a two-hundred day simple moving average of $313.13. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70. The Cigna Group has a 52 week low of $262.03 and a 52 week high of $370.83. The firm has a market capitalization of $92.71 billion, a price-to-earnings ratio of 27.68, a P/E/G ratio of 0.98 and a beta of 0.50.

The Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same quarter in the prior year, the firm earned $6.79 EPS. As a group, analysts anticipate that The Cigna Group will post 29.77 earnings per share for the current fiscal year.

The Cigna Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, March 20th. Stockholders of record on Wednesday, March 5th were issued a dividend of $1.51 per share. The ex-dividend date was Wednesday, March 5th. This is a positive change from The Cigna Group's previous quarterly dividend of $1.40. This represents a $6.04 dividend on an annualized basis and a dividend yield of 1.78%. The Cigna Group's payout ratio is 49.35%.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.